Exploring the mechanism of Huhuang decoction promoting diabetic wound healing based on network pharmaco-logy and transcriptomics

doi:10.16138/j.1673-6087.2025.01.04

Abstract

Abstract:

Objective To investigate the effect and mechanism of Huhuang decoction on diabetic wound healing.Methods The active ingredients and target genes of each component of Huhuang decoction were queried through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database. The gene targets of diabetic foot ulcer were screened through the Comparative Toxicogenomics Database (CTD) and GeneCards database. The component-target interaction network was drawn using Cytoscape software draw and gene ontology（GO） and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed using DAVID. The wound tissue of diabetic rats was collected to undergo transcriptomic sequencing analysis. The effect of Huhuang decoction on wound healing of diabetic rats was verified in vivo, and the expressions of inflammatory factors interleukin 6 (IL-6), tumor necrosis factor α (TNF-α) and IL-1β in wound tissue were detected by enzyme-linked immunosorbent assay (ELISA). Results Network pharmacology and transcriptomic sequencing analysis showed that the potential targets of Huhuang decoction were closely related to inflammatory regulation. Local application of Huhuang decoction on the wound surface could promote the healing of diabetic wounds. Hematoxylin and eosin （HE） staining results displayed that Huhuang decoction promoted epithelialization of diabetic wounds.ELISA test results showed that Huhuang decoction could inhibit the expression of inflammatory factors IL-6, TNF-α and IL-1β in wound tissue. Conclusions Huhuang decoction could inhibit inflammation of diabetic wounds and promote wound healing.

Key words: Huhuang decoction, Diabetic wounds, Network pharmacology, Transcriptomics

CLC Number:

R587.1

ZHANG Jie, XU Shun, LIU Yan, SHI Yan. Exploring the mechanism of Huhuang decoction promoting diabetic wound healing based on network pharmaco-logy and transcriptomics[J]. Journal of Internal Medicine Concepts & Practice, 2025, 20(01): 18-23.

Figures/Tables 5

References 18

[1]	McDermott K, Fang M, Boulton AJM, et al. Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers[J]. Diabetes Care, 2023, 46(1):209-221. doi: 10.2337/dci22-0043 pmid: 36548709
[2]	Jiang P, Li Q, Luo Y, et al. Current status and progress in research on dressing management for diabetic foot ulcer[J]. Front Endocrinol (Lausanne), 2023,14:1221705.
[3]	Zhou X, Guo Y, Yang K, et al. The signaling pathways of traditional Chinese medicine in promoting diabetic wound healing[J]. J Ethnopharmacol, 2022,282:114662.
[4]	郭兵, 高晓燕, 戈霞辉, 等. 中药浸浴熏洗在四肢Ⅱ度烧伤创面治疗中的应用[J]. 中国美容医学, 2022, 31(12):44-48.
[5]	Zhang R, Zhu X, Bai H, et al. Network pharmacology databases for traditional Chinese medicine: review and assessment[J]. Front Pharmacol, 2019,10:123.
[6]	Worsley AL, Lui DH, Ntow-Boahene W, et al. The importance of inflammation control for the treatment of chronic diabetic wounds[J]. Int Wound J, 2023, 20(6):2346-2359.
[7]	Wang J, Yang P, Yu T, et al. Lactylation of PKM2 suppresses inflammatory metabolic adaptation in pro-inflammatory macrophages[J]. Int J Biol Sci, 2022, 18(16):6210-6225. doi: 10.7150/ijbs.75434 pmid: 36439872
[8]	陈雪莲, 刘琰. 程序性细胞死亡在慢性难愈合创面炎症反应中的作用研究进展[J]. 中华烧伤与创面修复杂志, 2024, 40(10):991-995.
[9]	Nirenjen S, Narayanan J, Tamilanban T, et al. Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes[J]. Front Immunol, 2023,14:1216321.
[10]	谭梅鑫. 托里消毒散调控创面炎症反应对糖尿病皮肤溃疡愈合的影响[D]. 长沙: 湖南中医药大学, 2023.
[11]	秦盼月, 柯瑾, 李静平. 糖尿病难愈创面的中医研究进展[J]. 云南中医中药杂志, 2020, 41(2):90-94.
[12]	张玉昌, 陈翔, 何波, 等. 炎症因子在糖尿病溃疡中的作用及中医药治疗前景[J]. 中国组织工程研究, 2024, 28(34):5544-5551.
[13]	廖韵诺, 赵凯丽, 郭宏伟. 中药网络药理学的研究应用与挑战[J]. 中草药, 2024, 55(12):4204-4213.
[14]	Aghababaei F, Hadidi M. Recent advances in potential health benefits of quercetin[J]. Pharmaceuticals (Basel), 2023, 16(7):1020.
[15]	Cho YC, Park J, Cho S. Anti-inflammatory and anti-oxidative effects of luteolin-7-O-glucuronide in LPS-stimulated murine macrophages through TAK1 inhibition and Nrf2 activation[J]. Int J Mol Sci, 2020, 21(6):2007.
[16]	Zhai H, Wang D, Wang Y, et al. Kaempferol alleviates adipose tissue inflammation and insulin resistance in db/db mice by inhibiting the STING/NLRP3 signaling pathway[J]. Endocr Connect, 2024, 13(5):e230379.
[17]	Yin H, Huang L, Ouyang T, et al. Baicalein improves liver inflammation in diabetic db/db mice by regulating HMGB1/TLR4/NF-κB signaling pathway[J]. Int Immunopharmacol, 2018,55:55-62.
[18]	Amor AJ, Gómez-Guerrero C, Ortega E, et al. Ellagic acid as a tool to limit the diabetes burden: updated evidence[J]. Antioxidants (Basel), 2020, 9(12):1226.